Hepatitis C Virus Infection and the Development of Type 2 Diabetes in a Community-based Longitudinal Study
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
The temporal relation of hepatitis C virus (HCV) infection to the development of type 2 diabetes remains unknown. The authors followed 4,958 persons aged > or =40 years without diabetes (3,486 seronegative, 812 anti-HCV+, 116 with hepatitis B virus/HCV coinfection, and 544 hepatitis B surface antigen (HBsAg)+) from a community-wide cohort in southern Taiwan for 7 years (1997-2003) to study the risk of diabetes associated with HCV infection. A total of 474 participants developed diabetes. The 7-year cumulative incidence was 7.5% for HBsAg+, 8.6% for seronegative, 14.3% for anti-HCV+, and 14.7% for coinfected participants. Compared with HCV- persons, HCV+ persons had a higher cumulative incidence of diabetes (log-rank test, p < 0.0001). A multivariate Cox proportional hazards model showed that anti-HCV+ (hazard ratio = 1.7, 95% confidence interval: 1.3, 2.1), coinfection (hazard ratio = 1.7), overweight, obesity, and increasing age were significantly associated with diabetes (p < 0.05). Gender, educational level, HBsAg+ status, alcohol consumption, and smoking were not significant. After stratification by age and body mass index, the risk ratio for diabetes in anti-HCV+ participants increased when age decreased and body mass index levels increased (p < 0.001). Results show that HCV infection is an independent predictor of diabetes, especially for anti-HCV+ persons who are younger or have a higher body mass index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Associations have been made between certain pathogens and T2D risk: herpes simplex virus type 1 and hepatitis C virus are risk factors for T2D, although it is not clear how this can be mechanistically explained.86,87”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [87]
Citations
Cites
(2004) · The Lancet · doi:10.1016/s0140-6736(03)15268-3 · Cited by 12,717
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883 · cited 3×
“Hepatitis C virus (HCV) infection and type 2 diabetes are two worldwide, major public health problems with increasing complication and mortality rates (1, 2).”
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
Lauer, G. M., & Walker, B. D. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107053450107 · Cited by 2,973
Primary liver cancer: Worldwide incidence and trends
Bosch, F. X., Ribes, J., Díaz, M., & Cléries, R. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.011 · Cited by 2,477 · cited 1×
“Hepatitis B virus (HBV) and HBV/HCV coinfections are well-known etiologic factors related to hepatocellular carcinoma (21).”
Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma
El-serag, H. B., Tran, T., & Everhart, J. E. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.10.065 · Cited by 1,230 · cited 1×
“Second, the comorbidity of diabetes and HCV infection at a younger age might exacerbate liver problems because these two conditions greatly increase the progression of hepatic fibrosis (26) and the risk of hepatocellular carcinoma (27).”
The Natural History of Hepatitis C Virus Infection: Host, Viral, and Environmental Factors
Thomas, D. L., Astemborski, J., Rai, R. M., Anania, F. A., Schaeffer, M., Galai, N., Nolt, K., Nelson, K. E., Strathdee, S. A., Johnson, L., et al. (2000) · JAMA · doi:10.1001/jama.284.4.450 · Cited by 1,073 · cited 1×
“First, HCV-RNA was not tested to elucidate the relation between actual viral status and past infection, and 15–26 percent of the anti-HCVþ participants were HCV-RNA and indicated past infection (2, 37).”
Screening for type 2 diabetes.
Engelgau, M. M., Narayan, K. M., & Herman, W. H. (2000) · Diabetes Care · doi:10.2337/diacare.23.10.1563 · Cited by 1,027
Shintani, Y., Fujie, H., Miyoshi, H., Tsutsumi, T., Tsukamoto, K., Kimura, S., Moriya, K., & Koike, K. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.11.056 · Cited by 763 · cited 3×
“Insulin resistance was recently confirmed in an experiment using a transgenic mouse model with an HCV core gene (34).”
InfluentialInsulin resistance is associated with chronic hepatitis C and virus infection fibrosis progression
Hui, J. M., Sud, A., Farrell, G. C., Bandara, P., Byth, K., Kench, J. G., McCaughan, G. W., & George, J. (2003) · Gastroenterology · doi:10.1053/j.gastro.2003.08.032 · Cited by 718 · cited 1×
“Second, the comorbidity of diabetes and HCV infection at a younger age might exacerbate liver problems because these two conditions greatly increase the progression of hepatic fibrosis (26) and the risk of hepatocellular carcinoma (27).”
Cited by
Type 2 diabetes incidence and socio-economic position: a systematic review and meta-analysis
Agardh, E., Allebeck, P., Hallqvist, J., Moradi, T., & Sidorchuk, A. (2011) · International Journal of Epidemiology · doi:10.1093/ije/dyr029 · Cited by 1,014
Pan, A., Wang, Y., Talaei, M., Hu, F. B., & Wu, T. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00316-2 · Cited by 551
Hepatitis C infection and risk of diabetes: A systematic review and meta-analysis
White, D. L., Ratziu, V., & El-Serag, H. B. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.08.006 · Cited by 451
“Although the preponderance of current evidence suggests hepatitis C infection may convey additional DM risk beyond that conveyed by BMI, additional prospective studies are therefore needed to sort out the important aspect of the interaction between HCV infection and other risk factors for diabetes including current an…”
BackgroundMethodResultInfluentialReed, J., Bain, S., & Kanamarlapudi, V. (2021) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s319895 · Cited by 441
Extrahepatic Morbidity and Mortality of Chronic Hepatitis C
Negro, F., Forton, D., Craxì, A., Sulkowski, M. S., Feld, J. J., & Manns, M. P. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.08.035 · Cited by 361
Metadata
- Authors
- Wang, C.-S., Wang, S.-T., Yao, W.-J., Chang, T.-T., & Chou, P.
- Affiliations
- National Yang Ming University (TW)
- National Cheng Kung University (TW)
- Venue
- American Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-06-07
- Volume
- 166
- Issue
- 2
- Pages
- 196-203
- ISSN
- 0002-9262 (ISSN-L)
- 1476-6256
- OpenAlex
- W2130453232
- Cited by
- 166
- References
- 36
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 1 · 2023: 5 · 2022: 6 · 2021: 5 · 2020: 6 · 2019: 9 · 2018: 7 · 2017: 15 · 2016: 13 · 2015: 15 · 2014: 6 · 2013: 6 · 2012: 11
- FWCI
- 10.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Epidemiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Hepatitis C virus research
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- hepatitis C, type 2 diabetes, diabetes risk factors, hepatitis B surface antigen, obesity, body mass index, age, cumulative incidence, community-based cohort
- MeSH terms
- Adult, Diabetes Mellitus, Type 2, Female, Hepatitis B, Hepatitis B Surface Antigens, Hepatitis C, Humans, Longitudinal Studies, Male, Middle Aged, Obesity, Risk, Taiwan, Incidence, Proportional Hazards Models
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hepatitis C Virus Infection and the Development of Type 2 Diabetes in a Community-based Longitudinal Study. https://app.cochat.ai/papers/10.1093/aje/kwm061
- The paper
- Wang, C.-S., Wang, S.-T., Yao, W.-J., Chang, T.-T., & Chou, P. (2007). Hepatitis C Virus Infection and the Development of Type 2 Diabetes in a Community-based Longitudinal Study. American Journal of Epidemiology. https://doi.org/10.1093/aje/kwm061
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.